KUALA LUMPUR, June 23 (Bernama) — DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring (CGM) for people with diabetes headquartered in San Diego, California, has chosen Batu Kawan Industrial Park as their third manufacturing site. This new site, the first outside of the United States (US), will help increase the production of Dexcom’s industry-leading CGM systems.
YB Dato’ Seri Mohamed Azmin Ali, Senior Minister and Minister of International Trade and Industry (MITI), in welcoming Dexcom into Malaysia’s medical devices ecosystem, said, “This is an excellent example of how global companies are making their decisions based on investment fundamentals. Despite the current pandemic, Malaysia remains an attractive investment destination due to its diversified economy and comprehensive ecosystem. These offer companies the potential to realise many business opportunities.”